Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study

Additional Metadata
Persistent URL	doi.org/10.1002/cpt.1331, hdl.handle.net/1765/117168
Journal	Clinical Pharmacology and Therapeutics
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Man, F., Hussaarts, K., de With, M., Oomen - de Hoop, E., de Bruijn, P., van Halteren, H., … Mathijssen, R. (2018). Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study. Clinical Pharmacology and Therapeutics, 105(6), 1456–1461. doi:10.1002/cpt.1331

Publication